News
British drugmaker GSK said on Monday that the U.S. Food and Drug Administration has accepted its application for priority ...
Every year, the FDA approves novel drugs, biosimilars, and first generics. Compared to 2024, novel drug and biosimilar approval numbers are slightly behind in the first half of 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results